Errata

In the article “Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target” by L. A. Marlow, J. D'Innocenzi, Y. Zhang, S.D. Rohl, S. J. Cooper, T. Sebo, C. Grant, B. McIver, J. L. Kasperbauer, J. T. Wadsworth, J. D. Casler, P. W. Kennedy, W. E. Highsmith, O. Clark, D. Milosevic, B. Netzel, K. Cradic, S. Arora, C. Beaudry, S. K. Grebe, M. L. Silverberg, D. O. Azorsa, R. C. Smallridge, and J. A. Copland (J Clin Endocrinol Metab 95:5338–5347; 2010; doi:10.1210/jc.2010-1421), the authors have been notified by Antonio Di Cristofano and Kristy Kang (Albert Einstein College of Medicine) that in Figure 2A (page 5341) the PI3KCA mutation for THJ-16T is actually G1633A and not C1622T. The authors apologize for this error.